Dr. Mehdi Shishehbor Appointed CMO of Inquis Medical

July 12, 2023—Inquis Medical, Inc., a privately held medical device company focused on peripheral vascular innovations based in Redwood City, California, announced the appointment of interventional cardiologist Mehdi H. Shishehbor, DO, as Chief Medical Officer.

Inquis Medical is developing treatments for the management of venous thromboembolic (VTE) diseases that aim to address the limitations of current lytic-free aspiration thrombectomy procedures, stated the company.

Dr. Shishehbor is the President of University Hospitals Harrington Heart and Vascular Institute in Cleveland, Ohio, where he is the Angela and James Hambrick Master Clinician in Innovation. Dr. Mehdi Shishehbor is also Director, Interventional Cardiovascular Center, University Hospitals; Co-Director, Vascular Center, Harrington Heart and Vascular Institute, University Hospitals; and Professor, Case Western Reserve University School of Medicine in Cleveland.

The company noted that Dr. Shishehbor has led numerous international trials and is a National Institutes of Health scholar and winner of numerous national and international awards, including the prestigious Thomas J. Linnemeier Spirit of Interventional Cardiology Young Investigator Award and the VIVA/LINC Young Leader’s Award in Vascular. Additionally, he is a widely published author and researcher. His work on cardiovascular epidemiology and interventional cardiology outcomes and techniques has been published in leading medical journals.

Dr Shishehbor is Cofounder of the not-for-profit Cardiovascular Innovations Foundation, which hosts the annual CVI conference. He has trained > 400 physicians on endovascular techniques and served as the Director of Endovascular Services at Cleveland Clinic from 2009 to 2017.

Mojgan Saadat, President and Cofounder of Inquis Medical, commented in the company’s press release, “We are pleased to welcome Dr. Mehdi Shishehbor to our team. Dr. Shishehbor is an internationally recognized thought leader in thromboembolic diseases and brings extensive clinical and scientific expertise that will contribute to our mission to deliver pioneering products to help patients suffering from peripheral thromboembolic diseases. His clinical perspective will help Inquis Medical build technologies that best support the clinician, driving adoption and improved outcomes.”

Dr. Shishehbor stated in the press release, “I am excited to join the Inquis Medical team. Their novel solution tackles the pain points inherent in current VTE treatment approaches and underscores the forward-thinking approach of the Inquis team.”

Dr. Shishehbor added, “Inquis Medical’s thrombectomy system enhances procedural efficiency by providing operators with improved control and precision. I look forward to collaborating with this innovative team.”

Inquis Medical also announced that Bruce Shook has joined its Board of Directors as an independent director. Shook is a medical technology entrepreneur with > 35 years of industry experience. Most recently, he was the CEO of Intact Vascular and Vesper Medical, two peripheral vascular companies acquired by Royal Philips.

Inquis Medical’s CEO and Cofounder Vahid Saadat stated in the press release “Bruce Shook brings over 3 decades of experience to Inquis Medical. His stellar track record of successfully developing and commercializing new medical technologies will be invaluable to Inquis Medical as we prepare to bring our transformative technology to the thrombectomy market.”